DANIELLA KOEHLER: Open Payments
NPI 1841763042 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 35 payments from 11 companies in 2025. Trend: 2023 $1,965 · 2024 $1,695 · 2025 $834
Food & beverage: $734Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $192 |
| AstraZeneca Pharmaceuticals LP | 8 | $172 |
| JAZZ PHARMACEUTICALS INC. | 1 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $80 |
| Insmed, Inc. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| Grifols USA, LLC | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $28 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: NUCALA, XYWAV, FASENRA, OFEV, TRELEGY ELLIPTA, Arikayce, DUPIXENT, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
